摘要
目的探讨血管生成素样蛋白3(ANGPTL3)、葡萄糖激酶调节蛋白(GCKR)基因单核苷酸多态性(SNP)与代谢综合征(MS)的关系。方法随机选取2012年1月至2013年1月于该校附属医院接受治疗的100例MS患者,选取同期的100例健康体检者作为对照。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析GCKR基因rs780094,ANGPTL3基因rs112079972个位点的多态性与MS的关系。结果 ANGPTL3rs11207997位点TT基因型携带者高密度脂蛋白(HDL)-C、载脂蛋白(Apo)A1水平明较低;GCKRrs780094TT基因型携带者三酰甘油(TG)、口服葡萄糖耐量试验(OGTT)3h血糖水平高于CC、CT基因型携带者,OGTT1h胰岛素水平低于CC、CT基因型携带者(P<0.05);ANGPTL3rs11207997位点CT、TT基因型携带者比CC基因型携带者发生MS的风险分别上升1.398和3.180倍;GCKRrs780094TT基因型携带者发生MS的风险上升2.150倍(P<0.05)。结论 ANGPTL3rs11207997、GCKRrs780094位点的SNP与MS的发生有密切关系,可以提高MS发病的风险。
Objective To investigate the correlation between single nucleotide polymorphisms (SNP) of ANGPTL3,GCKR and metabolic syndrome (MS). Methods 100 MS patients and 100 normal subjects in our hospital from January 2012 to January 2013 were selected randomly. PCR-RFLP was used to analyze whether there was a correlation between SNP of GCKR gene rs780094, ANGPTL3 gene SNP rs11207997 and metabolic syndrome. Results The levels of HDL-C and ApoA1 of subjects with ANGPTL3 rs11207997 TT genotype were significantly lower than that of subjects with CC,CT genotype; The triglycerides and OGTT 3 h glucose of people with GCKR rs780094 TT genotype were significantly higher than that of people with the CC,CT genotype,OG- TT l h insulin level was significantly lower than that of people with the CC,CT genotype (P〉0.05); CT, TT genotypes of AN- GPTL3 rs11207997 increased the risk of developing MS by 1. 398 and 3. 180 times;TT genotype of GCKR rs780094 increased risk occurring MS by 2. 150 times (P〉0.05). Conclusion The SNPs of ANGPTL3 rs11207997 and GCKR rs 780094 are closely corre- lated to the occurrence of MS and can increase the risk of MS.
出处
《国际检验医学杂志》
CAS
2014年第3期271-274,共4页
International Journal of Laboratory Medicine
基金
湖南省教育厅科研项目(12C1195)
关键词
多态性
单核苷酸
代谢综合征
多态性
限制性片段长度
血管生成素样蛋白3
葡萄糖激酶调节蛋白
聚合酶链反应
polymorphism, single nucleotide
metabolic syndrome
polymorphism, restriction fragment length
angiopoie- tin like protein 3
glucokinase regulatory protein
polyrnerase chain reaction